Life sciences contributed £43.3 billion to UK economy in 2021

19 October 2023
uk_london_large

The life sciences sector contributed £43.3 billion ($52.6 billion) to the UK economy in 2021 through production of goods and services, with pharma manufacturing responsible for a majority of £19.2 billion.

So says analysis from accounting giant PwC in its Life Sciences Future50 report, which identifies 50 UK firms seeking to tackle challenging problems in the human health and science space.

"It is critical that we boost the availability of late-stage funding and infrastructure capacity to enable these companies to flourish"The sector has seen strong growth since before the pandemic in 2019, with a 17.6% rise from £36.9 billion in gross value added (GVA) in two years, the analysis found.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical